Galera Therapeutics Inc.
13F holders, Q1 2024 (March 31)36holders
1famous investor
$0.14avg. 13F price*
At the end of Q1 2024, 36 institutions reported holding Galera Therapeutics Inc. in their 13F filings. The largest holders were Gsa Capital Partners LLP ($509K), Blackstone Inc. ($235K) and Aberdeen Group plc ($126K). One famous investor held it Israel Englander (0.0% of Millennium Management's portfolio).
- Company
- Galera Therapeutics Inc.
- CUSIP
- 36338D108
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $123K |
| Exits | 8 | $590K |
Ownership 36 holders
| Gsa Capital Partners LLP | 0.04% | Reduce -6.7% | 3,632,627 | $509K |
| Blackstone Inc. | 0.00% | No change | 1,678,984 | $235K |
| Aberdeen Group plc | 0.00% | No change | 898,374 | $126K |
| Nan Fung Group Holdings Ltd | 0.08% | No change | 613,223 | $86K |
| Vanguard Group Inc. | 0.00% | No change | 448,330 | $63K |
| Geode Capital Management, LLC | 0.00% | No change | 440,349 | $62K |
| BlackRock Inc. | 0.00% | Reduce -0.1% | 357,192 | $50K |
| Atom Investors LP | 0.01% | New | 356,204 | $50K |
| UBS Group AG | 0.00% | Add +2302.8% | 293,502 | $41K |
| Susquehanna International Group, LLP | 0.00% | New | 286,180 | $40K |
| Summit Trail Advisors, LLC | 0.00% | New | 147,658 | $21K |
| State Street Corp. | 0.00% | No change | 106,564 | $15K |
| Millennium Management | 0.00% | New | 76,630 | $11K |
| Manchester Financial Inc. | 0.00% | Add +227.3% | 72,000 | $10K |
| Northern Trust Corp. | 0.00% | No change | 69,029 | $10K |
| Royal Bank of Canada | 0.00% | Reduce -1.2% | 35,403 | $5K |
| Group One Trading LLC | 0.00% | Reduce -49.6% | 32,720 | $5K |
| Kestra Advisory Services, LLC | 0.00% | Reduce -9.8% | 32,250 | $5K |
| Good Life Advisors, LLC | 0.00% | No change | 31,250 | $4K |
| Level Four Advisory Services, LLC | 0.00% | No change | 26,441 | $4K |
| XTX Topco Ltd | 0.00% | Reduce -36.5% | 25,246 | $4K |
| Bank of New York Mellon Corp | 0.00% | No change | 22,020 | $3K |
| Vontobel Holding Ltd. | 0.00% | No change | 20,000 | $3K |
| LPL Financial LLC | 0.00% | Add +1.5% | 18,102 | $3K |
| HRT Financial LP | 0.00% | Add +6.1% | 15,782 | $2K |
| Two Sigma Securities, LLC | 0.00% | New | 12,143 | $2K |
| J.W. Cole Advisors, Inc. | 0.00% | No change | 12,000 | $2K |
| Parallel Advisors, LLC | 0.00% | No change | 7,867 | $1K |
| Natixis | 0.00% | No change | 5,000 | $774 |
| US Bancorp \de | 0.00% | No change | 3,000 | $420 |
| Morgan Stanley | 0.00% | No change | 2,831 | $396 |
| Wells Fargo & Company | 0.00% | Add +6.1% | 1,391 | $195 |
| LifeSteps Financial, Inc. | 0.00% | New | 870 | $122 |
| FMR LLC | 0.00% | New | 757 | $106 |
| JPMorgan Chase & Co. | 0.00% | No change | 24 | $3 |
| Qube Research & Technologies Ltd | 0.00% | No change | 2 | $0 |
"% of holder's portfolio" is GALERA THERAPEUTICS INC's weight in each manager's 13F, not the share of Galera Therapeutics Inc. the manager owns.